Position in INDV
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$8,154,314
New position
Shares Held
267,530
first reported quarter
Ownership
0.219%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026OP Asset Management Ltd holds $46,195,528 across 10 Drug Manufacturers - Specialty & Generic names. INDV ranks #4 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,252,863 | $11,927,255 | |
| 2 | ZTS |
Zoetis Inc.
|
96,307 | $11,384,450 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
341,444 | $8,170,754 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
267,530 | $8,154,314 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
4,588 | $2,720,592 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
18,506 | $2,437,980 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
36,061 | $748,626 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
8,163 | $421,945 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,154,314 | 267,530 | Shares | Sole | 2026-04-10 | |
| No filing history on record for this holder in this stock. | ||||||